Reassessing the risk-modifying effects of novel antidiabetic agents on asthma–COPD overlap syndrome: a dose-stratified network meta-analysis of 316,832 adults from 128 randomised trials

Authors:

Abstract
No abstract available
Funding Information
  • King's College London
  • National Science and Technology Council (112-2314-B-182-070-MY3)
  • Maudsley Charity
  • National Institute for Health and Care Research
  • South London and Maudsley NHS Foundation Trust

This publication has 152 references indexed in Scilit: